European Archives - Page 611 of 1106 - European Medical Journal

Could STAR-CAP be the New Prostate Cancer Staging System?

PROSTATE cancer is one of the most common cancers worldwide, yet it remains one of the few cancers not to adopt the familiar staging system of Stage I–IV…

COVID-19 Delays Could Have a Profound Impact on Breast Cancer Outlook

DELAYS in treatment, as a result of the coronavirus disease (COVID-19) pandemic, have been experienced by many people with cancer across the world.

Male Sex May Be the Defining Factor in Predicting Susceptibility to and Severity of SARS-CoV-2 Infection: A Case Series

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes the coronavirus disease (COVID-19)…

One in Five Patients Undergoing Major Surgery Develop Heart Complications

Major noncardiac surgery leads to development of one or more heart complications within a year for one in five patients.

Low Risk of Moderate or Severe COVID-19 in Congenital Heart Disease

SARS-CoV-2 infection in patients with congenital heart disease (CHD) is associated with a low risk of moderate or severe coronavirus disease

EMJ Podcast: The Slower Moving Pandemic

Jonathan chats to Professor Sabiha Essack, Research Chair in Antibiotic Resistance and One Health, University of KwaZulu-Natal.

EMJ Nephrology [Supplement 4] 2020 Feature Image

Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis: From Diagnosis to Outcomes

AAV encompasses a rare group of severe, progressive autoimmune diseases that involve a necrotising vasculitis and can affect many vital organs including…

EMJ Nephrology [Supplement 4] 2020 Feature Image

EMJ Nephrology 8 [Supplement 4] 2020

“ANTI-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis: From Diagnosis to Outcomes,” reviews posters presented at…

ESC Congress 2020: Overview of Updated Heart Failure Trials and Promising Drugs

The ESC Congress 2020 presented several promising clinical trials that may potentially change our practice in heart failure management.

Talking to Ian Dorrian

Ian Dorrian, President Communications Europe, Syneos Health, talks about his journey from the pharmaceutical industry to the agency world, what pharma can do to mitigate the spread of fake news, and how long-term use of virtual communication could affect product launches of the future.